Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Allergan Inc (AGN)

2014-10-31@15:58:08 ET
Allergan (AGN) Trading Near $183.91 Support Level (FBM)

2014-10-31@07:40:08 ET
Global Hyaluronic Acid (HA) (Dermal Fillers, Osteoarthritis, Ophthalmic & VUR) Market Outlook, 2018 (MTO)

2014-10-30@08:34:12 ET
Potential Allergan (AGN) Trade Has 5.84% Downside Protection (FBM)

2014-10-30@06:26:09 ET
Botulinum Toxin - Global Strategic Business Report 2014-2020 (MTO)

2014-10-30@03:01:02 ET
(PRW)

2014-10-30@01:03:35 ET
Allergan Posts Third Quarter Results (CLM)

2014-10-29@15:11:05 ET
San Marcos Dentist, Jeffrey Allred, Certified by Allergan to Provide Botox to Patients Having Dental Problems (PRW)

2014-10-29@13:29:39 ET
Potential Allergan (AGN) Trade Has 5.70% Downside Protection (FBM)

2014-10-29@12:36:28 ET
Stock Investors Bid Up Shares of Allergan, Up 1.6% (F77)

2014-10-29@11:39:02 ET
Highest Operating Margin in the Pharmaceuticals Industry Detected for Pozen (POZN, DEPO, AGN) (F70)

2014-10-29@11:07:31 ET
M&A Navigator: Deal pipeline - 29 October (MTN)

2014-10-29@10:40:15 ET
Watch for Shares of Allergan (AGN) to Approach Resistance at $185.19 (F79)

2014-10-29@09:02:17 ET
ALLERGAN CANADA LAUNCHES A 3D JUVEDERM(R) VISUALIZATION IPAD APP POWERED BY MODIFACE (COL)

2014-10-29@09:02:02 ET
Allergan Canada Launches a 3D JUVEDERM(R) Visualization iPad App Powered by ModiFace (INW)

2014-10-28@11:36:02 ET
Salix Pharmaceuticals is Among the Companies in the Pharmaceuticals Industry With the Highest Free Cash Flow Per Share (SLXP, AGN, JNJ) (F70)

2014-10-28@11:05:09 ET
M&A Navigator: Deal pipeline - 28 October (MTN)

2014-10-28@10:28:14 ET
Allergan (AGN) Trading Near $189.05 Resistance Level (FBM)

2014-10-28@08:24:48 ET
Analysis of Relative Performance in the Pharmaceuticals Industry for Shares of Sanofi-Aventis (SNY, MRK, SLXP, JAZZ, AGN) (F70)

2014-10-28@06:09:15 ET
Global Postherpetic Neuralgia Clinical Trials Review, H2, 2014 (MTO)

2014-10-27@20:39:22 ET
Allergan IncCorporate Event Announcement Notice (WSH)